Flagship Harbor Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Flagship Harbor Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14,750	Closed	-$633K	–	2183
2020 Q2	$633K	Buy	14,750 +14,700	+29,400%	+$608K	0.09%	214
2020 Q1	$2K	Buy	+50	New	+$2.13K	﹤0.01%	1687

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Flagship Harbor Advisors's XPH Position: Q3 2020 in Review

Flagship Harbor Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2020, closing a stake of 14,750 shares — an estimated $633K sold.

Flagship Harbor Advisors first reported a position in XPH in Q1 2020 and held it in 2 quarters. The position peaked at $633K in Q2 2020. 72 funds tracked by Wall St. Rank hold XPH as of Q3 2020.

Flagship Harbor Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 14,750 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2020, an estimated $633K.
Flagship Harbor Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2020 and held it in 2 quarters.
Flagship Harbor Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $633K in Q2 2020.
72 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2020.

Based on Flagship Harbor Advisors's 13F filing for Q3 2020, filed 13 Oct 2020.